A 'breakthrough' drug to prevent HIV, an 'unprecedented' rollout

A pharmacist holds a vial of lenacapavir, described as a "breakthrough" HIV prevention drug, at a research site in South Africa.

The drug lenacapavir will be distributed to Eswatini and Zambia — the first step toward providing at least 2 million doses to the countries with the highest HIV burden, largely in Africa, by 2028.

(Image credit: Nardus Engelbrecht)